Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-27

FDA Approved: LOREEV XR — Original Application (Almatica Pharma LLC)

View source ↗

Summary

The FDA approved LOREEV XR, an extended-release formulation of lorazepam from Almatica Pharma LLC, through an original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOREEV XR (lorazepam)

Snippet

ORIG AP for LOREEV XR (LORAZEPAM)